Your browser doesn't support javascript.
loading
Meibomian Glands and Tear Film Findings in Type 2 Diabetic Patients: A Cross-Sectional Study.
Wu, Huping; Fang, Xie; Luo, Shunrong; Shang, Xumin; Xie, Zhiwen; Dong, Nuo; Xiao, Xianwen; Lin, Zhirong; Liu, Zuguo.
Afiliação
  • Wu H; Eye Institute and Affiliated Xiamen Eye Center of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
  • Fang X; Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen, China.
  • Luo S; Fujian Key Laboratory of Ocular Surface and Corneal Diseases, Affiliated Xiamen Eye Center of Xiamen University, Xiamen, China.
  • Shang X; Eye Institute and Affiliated Xiamen Eye Center of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
  • Xie Z; Fujian Key Laboratory of Ocular Surface and Corneal Diseases, Affiliated Xiamen Eye Center of Xiamen University, Xiamen, China.
  • Dong N; Eye Institute and Affiliated Xiamen Eye Center of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
  • Xiao X; Fujian Key Laboratory of Ocular Surface and Corneal Diseases, Affiliated Xiamen Eye Center of Xiamen University, Xiamen, China.
  • Lin Z; Eye Institute and Affiliated Xiamen Eye Center of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
  • Liu Z; Fujian Key Laboratory of Ocular Surface and Corneal Diseases, Affiliated Xiamen Eye Center of Xiamen University, Xiamen, China.
Front Med (Lausanne) ; 9: 762493, 2022.
Article em En | MEDLINE | ID: mdl-35479935

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Med (Lausanne) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Med (Lausanne) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China